Alphatec reaches highest price this year after solid Q2
This article was originally published in Clinica
Executive Summary
Shares in spinal disorders specialist Alphatec reached their highest price of the year on the Nasdaq after the company reported a 35% increase in sales for the second fiscal quarter.